Rekha Raghunathan

Rekha Raghunathan has extensive experience in the fields of bioanalytical and biomarker development, with a current role as Advisor and Scientist at Prevail Therapeutics since May 2021. Prior to this, Rekha served as Senior Scientist in Chemical Biology & Proteomics at AstraZeneca and worked as an Analytical Chemistry Intern at Agios Pharmaceuticals. Rekha's academic background includes a PhD in Molecular and Translational Medicine from Boston University, focusing on glycomics and proteomics related to aging, Parkinson’s disease, and cancer. Additional research experience includes positions at UTHSCSA and The University of Texas at San Antonio, where significant projects involved neurogenesis, biomarker discovery, and biodegradable scaffolds for tissue engineering.